Combination Treatment of Erythromycin and Furamidine Provides Additive and Synergistic Rescue of Mis-Splicing in Myotonic Dystrophy Type 1 Models

doi 10.1021/acsptsci.9b00020.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Myotonic Dystrophy Type 1

CMAJ
Medicine
2016English

Disease Burden of Myotonic Dystrophy Type 1

Journal of Neurology
Neurology
2019English

Dropped Head Presentation in Myotonic Dystrophy Type 1

Neurology India
Neurology
2005English

Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1

Frontiers in Physiology
Physiology
2018English

Laboratory Abnormalities in Ambulatory Patients With Myotonic Dystrophy Type 1

Archives of Neurology
2006English

Marathoning With Myotonic Dystrophy Type 2 (Proximal Myotonic Myopathy) and Leukopenia

SAGE Open Medical Case Reports
2017English

MRI of Tibialis Anterior as “Surrogate Measure” in Myotonic Dystrophy Type 1

Canadian Journal of Neurological Sciences
MedicineNeurology
2011English

Characteristic MRI Findings of Upper Limb Muscle Involvement in Myotonic Dystrophy Type 1

PLoS ONE
Multidisciplinary
2015English

Consensus-Based Care Recommendations for Congenital and Childhood-Onset Myotonic Dystrophy Type 1

Neurology: Clinical Practice
Neurology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy